title: [Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku].
authors.affiliation: TYKS:n sisätautien klinikka, Turku. kari.remes@tyks.fi
authors.forename: Kari
authors.initials: K
authors.lastname: Remes
authors.forename: Sini
authors.initials: S
authors.lastname: Luoma
authors.forename: Toivo T
authors.initials: TT
authors.lastname: Salmi
authors.forename: Pelliniemi
authors.initials: P
authors.lastname: Tarja-Terttu
authors.forename: Maija
authors.initials: M
authors.lastname: Itälä
authors.forename: Marjut
authors.initials: M
authors.lastname: Kauppila
authors.forename: Jukka
authors.initials: J
authors.lastname: Nikoskelainen
authors.forename: Mervi
authors.initials: M
authors.lastname: Putkonen
authors.forename: Veli
authors.initials: V
authors.lastname: Kairisto
authors.forename: Allan
authors.initials: A
authors.lastname: Rajamäki
authors.forename: Anri
authors.initials: A
authors.lastname: Tienhaara
authors.forename: Seppo
authors.initials: S
authors.lastname: Pyrhönen
authors.forename: Auvo
authors.initials: A
authors.lastname: Rauhala
mesh_terms: D000046:Academic Medical Centers; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D005260:Female; D005387:Finland; D006084:Graft Rejection; D006085:Graft Survival; D019337:Hematologic Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D018579:Patient Selection; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000592:standards* / Q000639:trends; D014184:Transplantation, Homologous; D016896:Treatment Outcome